Research Unite for Unknown Microbe, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Int Immunopharmacol. 2024 Jun 15;134:112169. doi: 10.1016/j.intimp.2024.112169. Epub 2024 May 10.
GUANKE is a Lactobacillus plantarum isolated from the feces of healthy volunteer. We have previously shown that GUANKE enhances the efficacy of the SARS-CoV-2 vaccine and prolongs the duration of vaccine protection by upregulating the IFN pathway and T and B lymphocyte functions of the host. The purpose of this study was to evaluate the protective effects and mechanism of oral administration of Lactobacillus plantarum GUANKE in the influenza (A virus A/Puerto Rico/8/34) infection mouse model. In our experiment, oral administration of GUANKE significantly decreased viral load and increased tight junction proteins expression in lung tissues of influenza-infected mice. After GUANKE was co-cultured with mBMDCs in vitro, mBMDCs' maturity and antiviral ability were enhanced, and matured mBMDCs induced polarization of naïve CD4 T cells into T helper (Th) 1 cells. Adoptive transfer of GUANKE-treated mBMDCs could protect mice from influenza infections. This study suggests that oral administration of Lactobacillus plantarum GUANKE could provide protection against influenza infection in mice, and this protective effect may be mediated, at least in part, by dendritic cells.
冠科是一株从健康志愿者粪便中分离得到的植物乳杆菌。我们之前的研究表明,冠科通过上调宿主的 IFN 途径和 T、B 淋巴细胞功能,增强了 SARS-CoV-2 疫苗的效力,并延长了疫苗保护的持续时间。本研究旨在评估口服植物乳杆菌冠科在流感(甲型 A 病毒 A/Puerto Rico/8/34)感染小鼠模型中的保护作用及其机制。在我们的实验中,口服冠科可显著降低流感感染小鼠肺部的病毒载量,并增加紧密连接蛋白的表达。体外将冠科与 mBMDC 共培养后,mBMDC 的成熟度和抗病毒能力增强,成熟的 mBMDC 诱导初始 CD4 T 细胞向辅助性 T 细胞(Th)1 细胞极化。过继转移经冠科处理的 mBMDC 可保护小鼠免受流感感染。本研究表明,口服植物乳杆菌冠科可提供对流感感染的保护作用,这种保护作用可能至少部分通过树突状细胞介导。